The mechanisms of how MLN4924 is effective for multiple myeloma has not been understood, but our data provide a tantalizing prospect that MLN4924 blocks neddylation of ribosomal protein such as L11, allowing vulnerability of nucleolus and activation of p53 pathway. The gene discussed is TP53; the disease is AL amyloidosis.